Longzhu Capital
VC Fund
Beijing, China
Longzhu Capital is a venture capital firm.
- Total investments:
- 65
- Last investment:
- Lead investor:
- 48%
- Fund size:
- $294M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Longzhu Capital invests in
Stages Longzhu Capital invests in
Countries Longzhu Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Guo Xuejing
|
|||
4 more contacts available
Investment Focus
Industry
- Food and Beverage 9 (14%)
- Manufacturing 6 (9%)
- Medical 3 (5%)
- Robotics 3 (5%)
- E-Commerce 3 (5%)
Stage
- Series B 15 (23%)
- Series A 14 (22%)
- Series C 6 (9%)
- Funding Round 4 (6%)
- Series D 3 (5%)
Country
- China 35 (54%)
- Nigeria 1 (2%)
- Hong Kong 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Guo Xuejing
Managing Director and Head of Medical
|
Managing Director and Head of Medical | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Snapmaker
|
Snapmaker is dedicated to providing an integrated platform empowering everyone to create things with ease that just wasn’t there before. | $147.1M / Series C / Jul 08, 2026 | |
kaye technology
|
Kaye Technology is a company that provides automation upgrade solutions for beverage equipment. | $58.9M / Series B / Jun 29, 2026 | |
Extreme shell technology
|
Extreme shell technology helps in creation and development of exoskeleton equipment for consumers. It uses data to drive exoskeleton innovation. | $50M / Series B / May 18, 2026 | |
|
Jiangxian Technology
|
Jiangxian Technology is a company focused on embodied intelligence, a field that integrates artificial intelligence with physical systems such as robots and smart devices, enabling machines to perceive, learn from, and interact with the real world in a more human-like and adaptive manner across applications like automation, healthcare, and advancedmanufacturing. | $73.4M / Angel / May 15, 2026 | |
|
Moonshot AI
|
Dark Side of the Moon is an AI large-scale model company. | $2B / Venture - Series Unknown / May 06, 2026 | |
|
Nova Fusion
|
Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors. | $102.5M / Angel / Apr 10, 2026 | |
D-Robotics
|
D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $150M / Series B / Mar 16, 2026 | |
X Square
|
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action. | Series A / Feb 25, 2026 | |
Galaxea AI
|
Xinghaitu is an intelligent robot technology company that specializes in the development of humanoid robots with embodied intelligence. | $144.7M / Series B / Feb 11, 2026 | |
Zhiran Medical
|
Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology. | $43.4M / Series A / Feb 11, 2026 | |
| See all 65 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Longzhu Capital invest in?
Longzhu Capital invests primarily in Food and Beverage, Manufacturing and Medical startups, most often at Series B and Series A stage. Most of the 65 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Longzhu Capital?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Longzhu Capital?
The team at Longzhu Capital includes Guo Xuejing (Managing Director and Head of Medical). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
